ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 33570 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 33570; 2) Community: the network communities that were significantly associated with the response to NSC 33570; 3) Molecule: the relationships between components within communities and NSC 33570; 4) MDR: the compounds that were significantly associated with the NSC 33570.

NSC Compound Enrichment Correlation
NSC 710181 Null 0.00433056621075589 0.19651079
NSC 743862 Null 0.00433056621075589 0.35914363
NSC 756169 GSK317314A 0.00433056621075589 0.1572416
NSC 113497 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) 0.00567322425730621 0.45129528
NSC 300289 Pinafide 0.00567322425730621 0.20871341
NSC 303861 L-Cysteine analog 0.00567322425730621 0.38143044
NSC 30915 Null 0.00567322425730621 0.44219178
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.00567322425730621 0.36895781
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.00567322425730621 0.35990531
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.00567322425730621 0.22652904
Total:112  Current:20    [First] [Prev] [Next] [Last]